Company: BIAF
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001840
Chunk: 1316

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 15
Chunk 1316
---
8-K (File No. 001-41463) filed with the SEC on October 21, 2024)

    10.40+
     
    Amendment No. 2 to Employment Agreement with Maria Zannes (Incorporated by reference as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No. 001-41463) filed with the SEC on January 14, 2025)

    10.41
     
    Form of Warrant Inducement Agreement (Incorporated by reference as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No. 001-41463) filed with the SEC on February 27, 2025)

 68 

    14.1
     
    Code of Business Conduct of the Registrant (Incorporated by reference as Exhibit 14.1 to the Registrant’s Form S-1 filed with the SEC on May 25, 2022)

    19.1*
     
    Amended
    and Restated Insider Trading Policy of the Registrant

    21.1
     
    List of Subsidiaries of the Registrant (incorporated by reference as Exhibit 21.1 to the Registrant’s Annual Report on Form 10-K filed with the SEC on April 1, 2024)

    23.1*
     
    Consent of WithumSmith+Brown, PC, independent registered public accounting firm

    31.1*
     
    Certification of Chief Executive Officer pursuant to Section 302 of Sarbanes-Oxley Act of 2002

    31.2*
     
    Certification of Chief Financial Officer pursuant to Section 302 of Sarbanes-Oxley Act of 2002

    32.1*
     
    Certification of Chief Executive Officer pursuant to Section 906 of Sarbanes-Oxley Act of 2002

    32.2*
     
    Certification of Chief Financial Officer pursuant to Section 906 of Sarbanes-Oxley Act of 2002

    97.1
     
    Clawback Policy (incorporated by reference as Exhibit 97.1 to the Registrant’s Annual Report on Form 10-K filed with the SEC on April 1, 2024)

    101.INS
     
    Inline
    XBRL Instance